Chronic Kidney Disease-Mineral and Bone Disorder
"Chronic Kidney Disease-Mineral and Bone Disorder" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Descriptor ID |
D012080
|
| MeSH Number(s) |
C05.116.198.816.750 C12.777.419.795 C13.351.968.419.795 C18.452.104.816.750 C18.452.174.845.750 C18.654.521.500.133.770.734.750 C19.642.355.480.500
|
| Concept/Terms |
Renal Osteodystrophy- Renal Osteodystrophy
- Osteodystrophies, Renal
- Renal Osteodystrophies
- Osteodystrophy, Renal
|
Below are MeSH descriptors whose meaning is more general than "Chronic Kidney Disease-Mineral and Bone Disorder".
Below are MeSH descriptors whose meaning is more specific than "Chronic Kidney Disease-Mineral and Bone Disorder".
This graph shows the total number of publications written about "Chronic Kidney Disease-Mineral and Bone Disorder" by people in this website by year, and whether "Chronic Kidney Disease-Mineral and Bone Disorder" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2017 | 12 | 1 | 13 |
| 2018 | 6 | 2 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Chronic Kidney Disease-Mineral and Bone Disorder" by people in Profiles.
-
Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients. Clin Chim Acta. 2018 Nov; 486:183-184.
-
[Update 2017 of the KDIGO guidelines on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). What are the real changes?] G Ital Nefrol. 2018 May; 35(3).
-
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. G Ital Nefrol. 2018 May; 35(3).
-
[Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease]. Nephrol Ther. 2018 Jun; 14(4):189-200.
-
CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy. J Nephrol. 2018 08; 31(4):585-591.
-
Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders. Calcif Tissue Int. 2018 08; 103(2):111-124.
-
Heterotopic Ossification in a Dialysis Patient. Dtsch Arztebl Int. 2018 02 02; 115(5):69.
-
Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White? Curr Vasc Pharmacol. 2018 01 26; 16(2):143-156.
-
Achieve Your Goals Together. The Easy and Reasonable Way to Treat Chronic Kidney Disease-Mineral Bone Disorder. Blood Purif. 2018; 45(1-3):71-72.
-
Sclerostin deficiency modifies the development of CKD-MBD in mice. Bone. 2018 02; 107:115-123.